A - Human Necessities – 61 – K
Patent
A - Human Necessities
61
K
A61K 39/00 (2006.01) A61K 39/40 (2006.01) A61K 39/42 (2006.01) C07K 16/10 (2006.01) A61M 1/34 (2006.01)
Patent
CA 2483551
Lowering the level of antibody or complement in the blood of a subject by plasmapheresis or exchange transfusion prior to administering an immunogenic therapeutic agent containing a foreign epitope reduces the immune response of the subject to the therapeutic agent.
Selon l'invention, la réduction du taux d'un anticorps ou d'un complément dans le sang d'un sujet par plasmaphérèse ou exsanguinotransfusion, avant l'administration d'un agent thérapeutique immunogène contenant un épitope étranger, permet de réduire la réponse immunitaire du sujet audit agent thérapeutique.
Buasen Pete T.
Cardin Sylvain
Lorence Robert M.
Gowling Lafleur Henderson Llp
Wellstat Biologics Corporation
LandOfFree
Immunogenic agent therapy using plasmapheresis or exchange... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Immunogenic agent therapy using plasmapheresis or exchange..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Immunogenic agent therapy using plasmapheresis or exchange... will most certainly appreciate the feedback.
Profile ID: LFCA-PAI-O-1460305